Kymera Therapeutics (KYMR) Competitor Comparison
We are evaluating the key criteria listed to compare Kymera Therapeutics (KYMR) against its competitors in the Biotechnology industry.
Market Capitalization
67 / 368Gross Profits
244 / 278Total Revenue
128 / 300EBITDA
274 / 337Free Cashflow
304 / 352Quick Ratio
168 / 357Earnings per Share
230 / 359Dividend yield
0 / 6Total Cash
86 / 358Performance 3 years
124 / 368Performance 5 years
106 / 368Performance 10 years
87 / 368Linearity 3 years
59 / 368Linearity 5 years
132 / 368Linearity 10 years
61 / 368Total Rank
177 / 368Dividend Rank
183 / 368Valuation Rank
212 / 368Piotroski Rank
241 / 368Muliplier Rank
136 / 368Piotroski Rank - KYMR ranking 241 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.